CYP2C19 loss-of-function carriers have increased risk of cardiac, but not limb, events following clopidogrel treatment for peripheral artery disease revascularization
CYP2C19 loss-of-function carriers have increased risk of cardiac, but not limb, events following clopidogrel treatment for peripheral artery disease revascularization. // JVS-Vascular Insights. – URL: https://www.sciencedirect.com/science/article/pii/S2949912726001777?dgcid=rss_sd_all
CYP2C19 loss-of-function carriers have increased risk of cardiac, but not limb, events following clopidogrel treatment for peripheral artery disease revascularization. JVS-Vascular Insights. https://www.sciencedirect.com/science/article/pii/S2949912726001777?dgcid=rss_sd_all
“CYP2C19 loss-of-function carriers have increased risk of cardiac, but not limb, events following clopidogrel treatment for peripheral artery disease revascularization.” JVS-Vascular Insights.
@article{article99023,
title = {CYP2C19 loss-of-function carriers have increased risk of cardiac, but not limb, events following clopidogrel treatment for peripheral artery disease revascularization},
journal = {JVS-Vascular Insights},
url = {https://www.sciencedirect.com/science/article/pii/S2949912726001777?dgcid=rss_sd_all}
}
ABSTRACT Objectives The aim of this study was to determine whether certain cephalometric findings can predict the future need for orthognathic surgery (OS) in cleft lip (CL), cleft palate (CP), unilateral cleft lip and palate (UCLP),...